Aptorum Group Ltd (APM)
3.90
-0.93
(-19.25%)
USD |
NASDAQ |
May 21, 14:26
Aptorum Group Total Liabilities (Quarterly): 5.257M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.257M |
| June 30, 2023 | 1.633M |
| June 30, 2023 | 1.633M |
| December 31, 2022 | 13.03M |
| June 30, 2022 | 8.370M |
| June 30, 2022 | 8.370M |
| December 31, 2021 | 4.401M |
| June 30, 2021 | 5.244M |
| June 30, 2021 | 5.244M |
| Date | Value |
|---|---|
| December 31, 2020 | 6.079M |
| June 30, 2020 | 5.787M |
| June 30, 2020 | 5.787M |
| December 31, 2019 | 9.102M |
| June 30, 2019 | 0.7181M |
| June 30, 2019 | 0.7181M |
| December 31, 2018 | 12.33M |
| June 30, 2018 | 16.95M |
| June 30, 2018 | 16.95M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.7181M
Minimum
Jun 2019
13.03M
Maximum
Dec 2022
5.425M
Average
5.257M
Median
Dec 2023
Total Liabilities (Quarterly) Benchmarks
| TC BioPharm (Holdings) PLC | 7.807M |
| Renalytix PLC | 19.88M |
| Immuron Ltd | 1.605M |
| Adaptimmune Therapeutics PLC | 233.64M |
| Biodexa Pharmaceuticals Plc | 7.470M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.64M |
| Shareholders Equity (Quarterly) | 24.85M |